The compound with CAS number 879551-04-9 is a nucleoside analog intermediate. Its structure is based on a modified purine or pyrimidine base linked to a sugar moiety, which is a core scaffold in nucleoside chemistry. This intermediate is specifically designed for chemical synthesis and structural modification. Its primary application is in the research and development of pharmaceutical agents, particularly antiviral and anticancer drugs. As a key building block, it is used to synthesize novel nucleoside analogs that can act as chain terminators or inhibitors of viral polymerases (like reverse transcriptase) or cellular enzymes involved in DNA/RNA synthesis. This makes it crucial for creating potential treatments for diseases such as hepatitis, HIV, and various cancers. The compound falls under the category of specialized pharmaceutical intermediates and is not a common, general-purpose synthetic reagent. Its value lies in its precise structure, which enables the introduction of specific functional groups to modulate the drug's activity, selectivity, and pharmacokinetic properties. Handling requires standard laboratory safety precautions for fine chemicals.